Form 4: Novavax COO John Trizzino Reports Stock Transactions
SEC Form 4
John Trizzino, President and COO of Novavax, reports the disposition of shares related to the vesting of restricted stock units.
Summary
- On March 1, 2025, John Trizzino, President and COO of Novavax, reported transactions involving Novavax common stock.
- Trizzino disposed of 48,000 shares of common stock upon the vesting of restricted stock units (RSUs).
- Additionally, Trizzino disposed of 23,185 shares to cover tax obligations at a price of $8.33 per share.
- Following these transactions, Trizzino directly owns 53,125 shares of Novavax common stock.
- Trizzino also directly owns 96,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard regulatory filing reporting stock transactions.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of stock transactions (vesting of RSUs and disposition for tax obligations). |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.